Role of biomarkers and endophenotypes in prevention and treatment of psychopathological disorders

Biomarkers in Medicine

Volumn 3, Issue 1, 2009, Pages 1-3

  Beauchaine, Theodore P ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; RISPERIDONE;

BIPOLAR DEPRESSION; CINGULATE GYRUS; COGNITIVE THERAPY; DISEASE MARKER; DISEASE PREDISPOSITION; EDITORIAL; GENETIC RISK; HERITABILITY; HIGH RISK POPULATION; HUMAN; LOW DRUG DOSE; MAJOR DEPRESSION; MENTAL DISEASE; PHENOTYPE; PREVALENCE; PRIMARY PREVENTION; SCHIZOPHRENIA; SMOOTH PURSUIT EYE MOVEMENT;

EID: 67650366997     PISSN: 17520363     EISSN: None     Source Type: Journal    
DOI: 10.2217/17520363.3.1.1     Document Type: Editorial

References (12)

1. Moore C, Breeze JL, Gruber S et al.: Choline, myo-inositol, and mood in bipolar disorder: a proton magnetic spectroscopic imaging study of the anterior cingulated cortex. Bipolar Disord. 2, 207-216 (2000).
2. Gould TD, Gottesman II: Psychiatric endophenotypes and the development of valid animal models. Genes Brain Behav. 5, 113-119 (2006).
3. Chan RCK, Gottesman II: Neurological soft signs as candidate endophenotypes in schizophrenia: a shooting star or a northern star? Neurosci. Biobehav. Rev. 32, 957-971 (2008).
4. Gottesman II, Gould TD: The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiatry 160, 636-645 (2003).
5. Korfine L, Lenzenweger MF: The taxonicity of schizotypy: a replication. J. Aborm. Psychol. 104, 26-31 (1995).
6. Grove WM, Clementz BA, Iacono WG, Katsanis J: Smooth pursuit ocular motor dysfunction in schizophrenia: evidence for a major gene. Am. J. Psychiatry 149, 1362-1368 (1992).
7. Beauchaine TP, Neuhaus E, Brenner SL, Gatzke-Kopp L: Ten good reasons to consider biological processes in prevention and intervention research. Dev. Psychopath. 20, 745-774 (2008).
8. Erlenmeyer-Kimling L, Golden RR, Cornblatt BA: A taxometric analysis of cognitive and neuromotor variables in children at risk for schizophrenia. J. Abnorm. Psychol. 98, 203-208 (1989).
9. Tyrka AR, Cannon TD, Haslam N et al.: The latent structure of schizotypy: I. Premorbid indicators of a taxon in individuals at risk for schizophrenia spectrum disorders. J. Abnorm. Psychol. 104, 173-183 (1995).
10. Beauchaine TP, Marsh P: Taxometric methods: enhancing early detection and prevention of psychopathology by identifying latent vulnerability traits. In: Developmental psychopathology. Theory and Method (2nd Edition). Cicchetti D, Cohen DJ (Eds). Wiley, Hoboken, NJ, USA (2000).
11. McGorry PD, Yung AR, Phillips LJ et al.: Randomized controlled trial of interventions designed to reduce the risk of progression to first episode psychosis in a clinical sample with subthreshold symptoms. Arch. Gen. Psychiatry 59, 921-928 (2002).
12. Beach SRH, Amir N: Is depression taxonic, dimensional, or both? J. Abnorm. Psychol. 112, 228-236 (2003).